Clinical trial
Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
NCT00497913 · Tehran University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00497913 |
|---|---|
| Title | Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis |
| Acronym | DCLE |
| Lead sponsor | Tehran University of Medical Sciences, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tennis Elbow |
| Intervention type | Drug |
| Interventions | NaCl 0.9%, Botulinum Toxin A |
| Enrollment | 52 |
| Start date | Aug 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jul 9, 2007 |
| Last update posted | Apr 23, 2008 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: